In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection

Transplantation

Volumn 59, Issue 8, 1995, Pages 1155-1161

  Chan, Sherri Y ^a   DeBruyne, Lisa A ^a,b   Goodman, Richard E ^a   Eichwald, Ernst J ^b   Bishop, D Keith ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; OKT 8; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HELPER CELL; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION;

ANIMAL; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DNA PRIMERS; EOSINOPHILS; FEMALE; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKINS; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029049485     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199504270-00014     Document Type: Article

References (49)

1. Steinmuller D. Which T cells mediate allograft rejection? Trans plantation 1985; 20: 229.
2. Hall B. Cells mediating allograft rejection. Transplantation 1991; 51: 1141.
3. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Ann Rev Immunol 1992; 10: 333.
4. Fitch FW, McKisic MD, Lancki DW, Gajewski TF. Differential regulation of murine T lymphocyte subsets. Ann Rev Immunol 1993; 11: 29.
5. Seder RA, Paul WE. Acquisition of lymphokine-producing phe notype by CD4+ T cells. Ann Rev Immunol 1994; 12: 635.
6. Romagnani S. Lymphokine production by human T cells in dis ease states. Ann Rev Immunol 1994; 12: 227.
7. Lowrv RP. Immunosuppression and selective T-helper subset function. Transplant Science 1993; 3: 190.
8. Bishop DK, Shelby J, Eichwald EJ. Mobilization of T lympho cytes following cardiac transplantation: evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Transplantation 1992; 53: 849.
9. Bishop DK, Li W, Chan SY, Ensley RD, Shelby J, Eichwald EJ. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4 positive cells: implications for cellular and humoral responses. Transplantation 1994; 58: 576.
10. Bishop DK, Chan S, Li W, Ensley RD, Xu S, Eichwald EJ. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 1993; 56: 892.
11. Corry RJ, Winn HS, Russell PS. Primarily vascularized al lografts of hearts in mice. Transplantation 1973; 16: 343.
12. Bishop DK, Orosz CG. Limiting dilution analysis for alloreac-tive, TCGF-secreting T cells: LDA methods that discriminate between unstimulated precursor T cells and in vivo alloacti-vated T cells. Transplantation 1989; 47: 671.
13. Glasebrook AL, Fitch FW. Alloreactive cloned T cell lines: inter actions between cloned amplifier and cytolytic T cell lines. J Exp Med 1980; 151: 876.
14. Orosz CG, Horstemeyer B, Zinn NE, Bishop DK. Development and evaluation of an LDA technique that can discriminate in vivo alloactivated CTL from their naive CTL precursors. Transplantation 1989; 47: 189.
15. Farrar J, Fuller-Farrar J, Simon P, Hilfiker M, Stadler B, Farrar W. Thymoma production of T cell growth factor (interleukin 2). J Immunol 1980; 125: 2555.
16. Ryser JE, MacDonald HR. Limiting dilution analysis of alloan-tigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J Immunol 1979; 122: 1691.
17. MacDonald HR, Cerottini JC, Ryser JE, et al. Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol Rev 1980; 51: 93.
18. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981; 126: 1614.
19. Bishop DK, Ferguson RM, Orosz CG. Differential distribution of antigen specific helper T cells and cytotoxic T cells following antigenic stimulation in vivo: a functional study using limiting dilution analysis. J Immunol 1990; 144: 1153.
20. Billingham ME, Cary NRB, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant 1990; 9: 587.
21. Trinchieri G. Interleukin-12 and its role in the generation of Thl cells. Immunol Today 1993; 14: 335.
22. Mosmann TR, Schumacher JH, Street NF, et al. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol Rev 1991; 123: 209.
23. Daynes RA, Araneo BA, Dowell TA, Huang K, Dudley D. Regu lation of murine lymphokine production in vivo: III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 1990; 171: 979.
24. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 1991; 254: 277.
25. Yamamura M, Wang XH, Ohmen JD, et al. Cytokine patterns of immunologically mediated tissue damage. J Immunol 1992; 149: 1470.
26. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J Exp Med 1989; 169: 59.
27. Taylor-Robinson AW, Phillips RS, Severn A, Moncada S, Liew FY. The role of Thl and Th2 cells in a rodent malaria infection. Science 1993; 260: 1931.
28. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 1992; 148: 3578.
29. Gautam SC, Chikkala NF, Hamilton TA. Anti-inflammatory action of IL-4: Negative regulation of contact sensitivity to trini-trochlorobenzene. J Immunol 1992; 148: 1411.
30. Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 1993; 151: 5666.
31. Sieling PA, Abrams JS, Yamamura M, et al. Immunosuppressive roles for IL-10 and IL-4 in human infection: in vitro modulation of T cell responses in leprosy. J Immunol 1993; 150: 5501.
32. Jayaraman S, Heiligenhaus A, Rodriguez A, Soukiasian S, Dorf ME, Foster CS. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. J Immunol 1993; 151: 5777.
33. Muller KM, Jaunin F, Masouye I, Saurat JH, Hauser C. Th2 cells mediate IL-4-dependent local tissue inflammation. J Immunol 1993; 150: 5576.
34. De Wit D, Van Mechelen M, Zanin C, et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol 1993; 150: 361.
35. Brok HPM, Heidt PJ, van der Meide PH, Zurcher C, Vossen JM. Interferon-γ prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Immunol 1993; 151: 6451.
36. Powell TJ, Streilein JW. Neonatal tolerance by class II alloanti-gens activates IL-4-secreting, tolerogen-responsive T cells. J Immunol 1990; 144: 854.
37. Schurmans S, Heusser CH, Qin HY, Merino J, Brighouse G, Lambert PH. In vivo effects of anti-IL-4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome. J Immunol 1990; 145: 2465.
38. Takeuchi T, Lowry RP, Konieczny B. Heart grafts in murine systems: the differential activation of Th2-like effectors in peripheral tolerance. Transplantation 1992; 53: 1281.
39. Krams SM, Falco DA, Villanueva JC, et al. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation 1992, 53: 151.
40. Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL, Krams SM. IL-2 and IL-5 gene expression in response to al-loantigen in liver allograft recipients and in vitro. Transplantation 1993; 55: 1159.
41. Martinez OM, Ascher NL, Ferrell L, et al. Evidence for a non-classical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation 1993; 55: 909.
42. Spry CJF, Kay AB, Gleich GJ. Eosinophils 1992. Immunol Today 1992; 13: 384.
43. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13: 501.
44. Dubucquoi S, Desreumaux P, Janin A, et al. Interleukin 5 syn thesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med 1994; 179: 703.
45. Tepper RI, Coffman RL, Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992; 257: 548.
46. Kemeny DM, Noble A, Holmes BJ, Diaz-Sanchez D. Immune regulation: a new role for the CD8+ T cell. Immunol Today 1994; 15: 107.
47. Fong TAT, Mosmann TR. Alloreactive murine CD8+ clones se crete the Thl pattern of cytokines. J Immunol 1990; 144: 1744.
48. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularized organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
49. Morgan CJ, Pelletier RP, Hernandez CJ, et al. Alloantigen-dependent endothelial phenotype and lymphokine mRNA expression in rejecting murine cardiac allografts. Transplantation 1993; 55: 919.